• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Hyperphosphatemia

Hyperphosphatemia - 26 Studies Found

Completed : Nicotinic Acid in Hemodialysis Patients With Hyperphosphatemia
: Hyperphosphatemia
: 2016-07-14
:
  • Drug: Nicotinic Acids Nicotini

Completed : A Long-term Study of PA21 in Hemodialysis Patients With Hyperphosphatemia
: Hemodialysis Patients With Hyperphosphatemia
: 2013-04-12
: Drug: PA21
Recruiting : Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)
: Hyperphosphatemia
: 2016-02-09
: Drug: sucroferric oxyhydroxide The non-interventional design allows the observation of patients in a bro
Recruiting : An Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia
: Hyperphosphatemia
: 2016-02-17
:
  • Drug: PA21 (Velphoro®)

Completed : Study to Evaluate the Efficacy and Safety of PT20 in Subjects With Hyperphosphataemia and Dialysis Dependent Chronic Kidney Disease
: Hyperphosphataemia
: 2014-05-28
:
  • Drug: PT20 Modified ferric oxi

Not yet recruiting : Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In China
: Hyperphosphatemia
: 2016-12-20
:
  • Drug: Placebo

Completed : A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
: Hyperphosphatemia
: 2016-11-11
:
  • Drug: EOS789
  • Drug: Placebo

Completed : An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
: Hyperphosphatemia
: 2016-02-03
:
  • Drug: Tenapanor Other Name: RD

Completed : Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis Patients
: Hyperphosphatemia
: 2012-01-18
: Drug: Lanthanum Carbonate (BAY77-1931)
Completed : Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium Carbonate
: Hyperphosphatemia
: 2012-01-18
:
  • Drug: Lanthanum carbonate (BAY77-1931)
  • Dru

Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.